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Abstract
Background: Almost 20 years ago, the frequencies of severe hypoglycemia requiring emergency medical
treatment were reported in people with types 1 and 2 diabetes in the Tayside region of Scotland. With
subsequent improvements in the treatment of diabetes, concurrent with changes in the provision of emergency
medical care, a decline in the frequency of severe hypoglycemia could be anticipated. The present population-
based data-linkage cohort study aimed to ascertain whether a temporal change has occurred in the incidence
rates of hypoglycemia requiring emergency medical services in people with types 1 and 2 diabetes.
Methods: The study population comprised all people with diabetes in Tayside, Scotland over the period 1
January 2011 to 31 December 2012. Patients’ data from different healthcare sources were linked anonymously to
measure the incidence rates of hypoglycemia requiring emergency medical services that include treatment by
ambulance staff and in hospital emergency departments, and necessitated hospital admission. These were
compared with data recorded in 1997–1998 in the same region.
Results: In January 2011 to December 2012, 2029 people in Tayside had type 1 diabetes and 21,734 had type 2
diabetes, compared to 977 and 7678, respectively, in June 1997 to May 1998. In people with type 2 diabetes, the
proportion treated with sulfonylureas had declined from 36.8 to 22.4% (p < 0.001), while insulin-treatment had
increased from 11.7 to 18.7% (p < 0.001). The incidence rate of hypoglycemia requiring emergency medical
treatment had significantly fallen from 0.115 (95% CI: 0.094–0.136) to 0.082 (0.073–0.092) events per person per
year in type 1 diabetes (p < 0.001), and from 0.118 (0.095–0.141) to 0.037 (0.003–0.041) in insulin-treated type 2
diabetes (p = 0.008). However, the absolute annual number of hypoglycemia events requiring emergency
treatment was 1.4-fold higher.
Conclusions: Although from 1998 to 2012 the incidences of hypoglycemia requiring emergency medical services
appeared to have declined by a third in type 1 diabetes and by two thirds in insulin-treated type 2 diabetes,
because the prevalence of diabetes was higher (2.7 fold), the number of severe hypoglycemia events requiring
emergency medical treatment was greater.
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Background
Hypoglycemia remains a common side-effect of the
treatment of diabetes with insulin despite the introduc-
tion of novel insulins, formulations and methods of de-
livery, coupled with advances in glycemic monitoring.
The epidemiology of severe hypoglycemia (defined as
any event requiring help for recovery) has been well doc-
umented in western countries [1], but is much more
common in many parts of the world than had been
recognised previously [2], as is non-severe (self-treated)
hypoglycemia, particularly during sleep [1]. In unselected
populations with type 1 diabetes in northern Europe the
incidence of severe hypoglycemia has been reported to
vary from 1.1 to 3.2 events per person per year [1, 3–8].
Population-based studies of emergency medical services
utilisation [9] have reported the incidence of hypoglycemia
requiring emergency treatment in people with type 1 dia-
betes to be between 0.08 and 0.49 events per person per
year. Severe hypoglycemia events in people with diabetes
account for 0.5% to 1.02% of all emergency ambulance call
outs in the UK per annum [10–13] where the frequency
of severe hypoglycemia and its treatment by emergency
medical services has been surveyed by opportunistic
examination of ambulance records [10, 11]. However, the
accuracy and validity of many such surveys were limited
by inadequate study design and retrospective review of
incomplete data.
Almost 20 years ago, the frequencies of severe
hypoglycemia events that required the assistance of
emergency medical services from primary care, ambu-
lance, hospital emergency and inpatient medical services
were recorded prospectively in detail over a 12-month
period (June 1997 to May 1998 inclusive) in people with
types 1 and 2 diabetes in the region of Tayside in
Scotland [12]. The incidences of severe hypoglycemia
events requiring emergency medical treatment were
0.115 events per person per year in type 1 diabetes,
0.118 in insulin-treated type 2 diabetes and 0.009 in
people with type 2 diabetes taking sulfonylureas, with re-
spective prevalence of 7.1%, 7.3%, and 0.8%. Many more
self-reported hypoglycemia events are treated by family
members, friends or colleagues who do not request help
from the emergency medical services [3, 12] and an
incidence of 1.15 events per person per year in type 1
diabetes and 0.35 events per person per year in insulin-
treated type 2 diabetes [12], were reported in the same
region. Around 63% to 73% people who experienced se-
vere hypoglycemia events remain at home following
treatment by ambulance paramedics [10, 11, 13], which
influences the frequency of treatment in hospital emer-
gency departments (EDs) and hospital admission. With
subsequent improvements in the treatment of diabetes,
combined with changes in methods of providing emer-
gency medical care, it could be anticipated that the
frequency of severe hypoglycemia events requiring emer-
gency treatment would have declined despite more in-
tensive management of diabetes being applied to attain
stricter glycemic control.
The present study aimed to re-measure the incidence
rates of severe hypoglycemia in types 1 and 2 diabetes
that had required emergency medical services in the
same region of Tayside over the period 1 January 2011
to 31 December 2012, and by comparison with the inci-
dence rates documented in 1997–1998, to ascertain
whether these had changed significantly over time.
Methods
Data sources and linkage
Data were derived from several sources. The Scottish
Care Information-Diabetes (SCI-Diabetes) provides an
integrated shared electronic patient record to support
the management of people with diabetes within the
National Health Service (NHS) in Scotland. It includes
information on type of diabetes, date of diagnosis and
treatment modality. The Scottish Ambulance Service
electronic patient records comprise the date of the
event, the symptoms, diagnosis of hypoglycemia and
treatment administered by ambulance clinicians to indi-
vidual patients, which can identify emergency call-outs
related to hypoglycemia. Data on admissions to EDs with
hypoglycemia were obtained from Information Services
Division Scotland. The Scottish Morbidity Register
(SMR01) dataset collects episode level data on hospital
inpatient and day case admissions from hospitals in
Scotland. It provides information on dates of admission
and discharge, and medical conditions, which can be
used to identify hospital admission associated with
hypoglycemia. Prescribing data were linked with diabetes
drugs with British National Formulary (BNF) codes, to
provide detailed information on the drugs dispensed. Data
on social deprivation were available for the 2011–12 co-
hort using the Scottish index of multiple deprivation
(SIMD) which is derived from the postcode via the com-
munity health index register [14]. The SIMD categories
patients into five divisions of deprivation.
Data were collected and collated by the Health Inform-
atics Centre in University of Dundee that conforms to
ISO27001. Data was linked using the Community Health
Index number that is used universally in the NHS with
over 99% of accuracy for people with diabetes in Scotland.
Study design and statistical analyses
The period of study was from 1 January 2011 to 31
December 2012, inclusive, and similar methodology was
used to that employed in the previous study [12], enab-
ling direct comparisons of incidence rates of severe
hypoglycemia to be made with 1997–1998. The study
population comprised all people with diabetes in
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Tayside, Scotland. All events of hypoglycemia that
required emergency medical services (ambulance, ED
attendance, and hospital admission) during the study
period were identified. The incidence of hypoglycemia
was analysed separately by type of diabetes. Type 1 dia-
betes was defined by requiring insulin within 6 months
of diagnosis and not taking any oral glucose-lowering
medication other than metformin. All other participants
were considered to have type 2 diabetes and were further
classified by the type of medications being prescribed in
order of their propensity to induce hypoglycemia:
a) Agents that do not usually cause hypoglycemia, (i.e.
metformin, pioglitazone, dipeptidyl peptidase-4
(DPP-4) inhibitors, sodium-glucose co-transporter-2
(SGLT-2) inhibitors, glucagon-like peptide-1 (GLP-
1) agonists).
b) Oral medications that may cause hypoglycemia, i.e.
sulfonylureas or glinides. This could be in
combination with medication in category a).
c) Treatment with insulin. This could be in combination
with a medication in either category a) or b).
The incidence rates were expressed as events per
person per year. The 95% confidence intervals were cal-
culated based on the maximum likelihood method for
Poisson-distributed observations. The incidence rate ra-
tios (IRRs) along with their 95% confidence intervals and
p values were calculated to assess the significance of dif-
ferences between the two populations in the same region
but at a different time period. All the analyses were con-
ducted in R version 3.2.5.
Results
Study cohort
A substantial increase in the prevalence of diabetes had
occurred in Tayside, Scotland during the 14 years
separating the two surveys. In June 1997 to May 1998,
of the 367,051 residents of Tayside, 8655 people had dia-
betes (crude overall prevalence = 2.4%), with 977 of
8655 (11.3%) having type 1 diabetes and 7678 (88.7%)
having type 2 diabetes (Table 1). The present study ex-
amined data from 23,763 people with diabetes (mid-year
population estimate in Tayside in 2012 = 411,749, crude
overall prevalence of diabetes during the 2 years from 1
January 2011 to 31 December 2012 = 5.8%), which in-
cluded 2029 with type 1 diabetes (8.5%) and 21,734 with
type 2 diabetes (91.5%).
Between June 1997 and May 1998, 69 of 977 people
with type 1 diabetes had experienced 112 hypoglycemia
events requiring emergency medical services, while 91 of
7678 people with type 2 diabetes had been treated for
132 events. From 1 January 2011 to 31 December 2012,
a total of 702 events of hypoglycemia requiring emer-
gency medical services were recorded in 467 people with
diabetes (Table 1). Some individuals had experienced re-
current episodes of hypoglycemia; 187 people with type
1 diabetes had experienced 319 events and 280 people
with type 2 diabetes had experienced 383 events.
From June 1997 to May 1998, among the 7678 people
with type 2 diabetes, 901 (11.7%) were being treated with
insulin (Table 2), 2823 (36.8%) were being treated with
sulfonylureas (group b), and 3954 (51.5%) were being
treated with non-insulin secretagogues alone (group a).
From 1 January 2011 to 31 December 2012, a signifi-
cantly higher proportion of people with type 2 diabetes
were receiving treatment with non-secretagogues
(58.9%) or insulin (18.7%), but fewer were being treated
with secretagogues (22.4%).
Incidence of severe hypoglycemia
The overall annual incidence rates of severe hypoglycemia
events requiring treatment by the emergency medical ser-
vices during the 2 years of the survey are shown for the
Table 1 People with diabetes and number of hypoglycemia events requiring emergency medical services in Tayside, Scotland
Type 1 diabetes Type 2 diabetes Total
June 1997 – May 1998
People with diabetes 977 (11.3%) 7678 (88.7%) 8655 (100%)
Mean age at study 33 66 –
Mean duration of diabetes (years) 17 8 –
People with severe hypoglycemia 69 91 160
Severe hypoglycemia events 112 132 244
1 January 2011–31 December 2012
People with diabetes 2029 (8.5%) 21,734 (91.5%) 23,763 (100%)
Mean age at study 40 68 –
Mean duration of diabetes (years) 18 7 –
People with severe hypoglycemia 187 280 467
Severe hypoglycemia events 319 383 702
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different treatment groups in Table 3. This was highest in
people with type 1 diabetes (0.082 events per person per
year, 95% CI: 0.073–0.092) and lowest in those with type 2
diabetes who were taking oral glucose-lowering medica-
tions that were not insulin secretagogues (group a).
Among people with type 2 diabetes, the insulin-treated
patients had a much higher incidence than those receiving
other types of treatment. By comparison with the period
of June 1997 to May 1998, significantly lower incidence
were observed in people with type 1 diabetes (IRR = 0.720,
95% CI: 0.580–0.892, p < 0.001) and people with type 2
diabetes receiving insulin (IRR = 0.314, 95% CI: 0.249–
0.395, p = 0.008). The IRRs for the groups receiving secre-
tagogues (group a) and non-secretagogues (group b) were
not calculated because the number of hypoglycemia
events in these two groups were not currently available for
the data from June 1997 to May 1998.
No information was available on ethnicity but the
prevalence of ethnic minorities is low at ≤3% in
Tayside, Scotland, and has not changed in the time
between these two surveys in what is a very stable
population. Data on social deprivation were not avail-
able from 1997 to 1998, but data from 2011 to 2012
showed an increasing trend in the incidence rate of se-
vere hypoglycemia in association with social deprivation
in type 1 diabetes (Table 4), but a similar trend was not
observed for different social deprivation categories in
insulin-treated type 2 diabetes.
Emergency medical services utilized
The number of hypoglycemia events requiring different
emergency medical services from 1 January 2011 to 31
December 2012 are shown in Fig. 1. Of the 702 events,
512 required emergency attendance by the ambulance
service, 150 were treated in the hospital emergency de-
partment, and 175 events resulted in direct or indirect
hospital admission. Any combination of these three emer-
gency medical services was utilized in 116 hypoglycemia
events. The proportion requiring inpatient hospital treat-
ment had slightly increased from 21% (52 of 244 events)
in 1997–1998 to 25% (175 of 702 events) in the period
from 1 January 2011 to 31 December 2012, whereas usage
of the ambulance service and of treatment in an emer-
gency department was less frequent, decreasing from 91%
(223 of 244) and 63% (153 of 244), respectively, to 73%
(512 of 702) and 21% (150 of 702). Overall, 124 of 383
(32%) events in type 2 diabetes and 51 of 319 (16%) events
in type 1 diabetes resulted in hospital admission. In
general, a 1.4-fold increase in the total number of severe
hypoglycemia events (244 events in 1997–1998 to an
average of 351 events per year in 2011 and 2012) was
recorded, compared to a 2.7-fold increase in the total
Table 2 Number of people (%) with type 2 diabetes and different types of treatment, including a) non-secretagogues e.g.
metformin, pioglitazone, DPP-4 inhibitor, SGLT-2 inhibitor, GLP-1 agonist; b) secretagogues e.g. sulfonylureas and glinides; and insulin
treated type 2 diabetes
Group of people
with type 2 diabetes
Number of people (%) Proportion difference
(95% CI)
P value
June 1997 – May 1998
(n = 7678)
1 Jan 2011–31 Dec 2012
(n = 21,734)
a) 3954 (51.5%) 12,812 (58.9%) 0.075 (0.062–0.087) < 0.001
b) 2823 (36.8%) 4859 (22.4%) −0.144 (−0.156 – −0.132) < 0.001
Insulin 901 (11.7%) 4063 (18.7%) 0.070 (0.061–0.078) < 0.001
Table 3 Incidence rates of hypoglycemia requiring emergency medical services. (Rates for patients with type 1 diabetes, type 2
diabetes treated with a) non-secretagogues, b) secretagogues, or insulin)
Group June 1997–May 1998 1 January 2011–31 December 2012
Incidence ratea
(95% CI)
Events
(person-years)
Incidence ratea
(95% CI)
IRRb
(95% CI)
P value
Type 1 0.115
(0.094–0.136)
319
(3867.35)
0.082
(0.073–0.092)
0.720
(0.580–0.892)
< 0.001
Type 2 a) 0.001
(0.000–0.002)
50
(22,100.36)
0.002
(0.002–0.003)
– –
b) 0.009
(0.006–0.013)
51
(9318.80)
0.005
(0.004–0.007)
– –
Insulin 0.118
(0.095–0.141)
282
(7601.69)
0.037
(0.033–0.041)
0.314
(0.249–0.395)
0.008
All type 2 0.017
(0.014–0.020)
383
(39,020.86)
0.010
(0.009–0.011)
0.571
(0.468–0.696)
< 0.001
aIncidence rate is expressed as events per person per year. bIRR incidence rate ratio
Wang et al. Clinical Diabetes and Endocrinology  (2017) 3:7 Page 4 of 8
diabetes population during the same period from 8655 to
23,763.
Discussion
While severe hypoglycemia remains a major clinical prob-
lem, particularly for people treated with insulin, this may
be declining in some patient groups. The present
population-based, data-linkage study within a single re-
gion of Scotland has demonstrated that a lower incidence
rate of severe hypoglycemia had required treatment by
emergency medical services compared to the frequency
observed 14 years earlier. While the incidence rate of se-
vere hypoglycemia in people with type 1 diabetes had de-
clined by about 30% (IRR = 0.720, 95% CI: 0.580–0.892,
p < 0.001), a more prominent fall was observed in people
with insulin-treated type 2 diabetes, which was almost
70% lower (IRR = 0.314, 95% CI: 0.249–0.395, p = 0.008).
However, although the incidence of severe hypoglycemia
had declined, the absolute number of events had increased
by 1.4 fold, in association with a 2.7-fold rise in the size of
the diabetes population in Tayside. A similar finding of a
lower incidence of severe hypoglycemia but a higher abso-
lute number requiring treatment in hospital was observed
over a 10-year period in a study in England [15], while a
higher absolute number of severe hypoglycemia events
was also reported in a German study [16]. This indicates
that the overall demand on the emergency medical
services to treat severe hypoglycemia is rising, despite a
decline in the incidence rate of severe hypoglycemia re-
quiring emergency medical treatment.
The prevalence of diabetes in Tayside, Scotland in
1997–1998 was identified from an accurately recorded
population-based data-linkage study [17]. While the
greater number of people with diabetes in 2011 and
2012 compared to 1997–1998 probably reflects a genu-
ine increase in prevalence of the disorder, it may partly
result from better case ascertainment, with fewer people
having undiagnosed diabetes and the observed preva-
lence is consistent with national prevalence statistics.
The mean duration of type 2 diabetes has also declined
from 1998 to 2011 and 2012, from 8 to 7 years, consist-
ent with earlier diagnosis.
The lower incidence rate of severe hypoglycemia in
type 1 diabetes that has now been observed may be a
consequence of more intensive diabetes education in
Tayside since 1998 [18] along with the greater use of
glucose monitoring and insulin pumps, and the intro-
duction of newer insulin analogues, which are associated
with a lower rate of hypoglycemia [19], particularly at
night. Although an overall reduction in the incidence
rate of severe hypoglycemia may have been offset by
greater efforts to improve glycemic control, the mean
HbA1c in people with hypoglycemia in 2011–2012 were
higher than in 1997–1998 for both type 1 and type 2
diabetes (Table 5). Poorer average glycemic control
could be one explanation as to why the incidence rate of
severe hypoglycemia events had declined, although in re-
cent years no deterioration in glycemic control has been
evidence in all patients with type 1 diabetes in Scotland
[20]. The more likely explanation is that it may be easier
to achieve good glycemic control without suffering
Table 4 Incidence rates of hypoglycemia requiring emergency
medical services in people with type 1 and insulin-treated type
2 diabetes across different categories of Scottish index of
multiple deprivation
Social deprivation Incidence rates of severe hypoglycemia (95% CI)
Type 1 diabetes Insulin-treated type 2 diabetes
1 (most deprived) 0.120 (0.093–0.147) 0.044 (0.033–0.054)
2 0.103 (0.078–0.128) 0.048 (0.036–0.059)
3 0.089 (0.069–0.108) 0.024 (0.016–0.031)
4 0.066 (0.051–0.081) 0.037 (0.029–0.045)
5 (least deprived) 0.041 (0.025–0.058) 0.032 (0.021–0.044)
Fig. 1 Number of hypoglycemia events requiring emergency medical services
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hypoglycemia, and thus hypoglycemia is relatively more
common in patients with erratic control and higher
mean HbA1c. The assumption that an inverse linear
relationship exists between the frequency of severe
hypoglycemia and HbA1c concentration is not sup-
ported by cross-sectional studies of both type 1 [21] or
type 2 diabetes [22], in which many people who experi-
ence recurrent severe hypoglycemia have elevated
HbA1c concentrations. This is consistent with severe
hypoglycemia being relatively common in people whose
glycemic control is poor.
In addition, the mean HbA1c values for 1997–98 and
2011–12 are not directly comparable as the ascertain-
ment of HbA1c measurements were approximately 80%
and 91% respectively, and patients not engaging with
medical services are more likely to have poor glycemic
control and are less likely to have HbA1c measured
regularly. The explanation for the increasing age of pa-
tients with type 1 diabetes having hypoglycemia may be
similar, with a greater proportion of younger patients re-
ceiving more modern insulins and or using continuous
subcutaneous insulin infusion with an insulin pump.
In the 14 years between the two studies the proportion
of people with type 2 diabetes treated with insulin had
risen significantly from 11.7 to 18.7% (Table 2), and the
absolute number of severe hypoglycemia events had in-
creased from 132 to an average of 191 events per year.
Despite the increase in the absolute number of events,
the incidence rate of severe hypoglycemia in people with
insulin-treated type 2 diabetes requiring emergency
medical treatment was significantly lower and may have
been promoted by changes in clinical management.
These include more comprehensive patient education,
the earlier use of insulin while significant β-cell function
is still preserved, which is associated with a lower risk of
hypoglycemia [23], and the earlier use of basal insulin in
combination with oral agents, including DPP-4 inhibi-
tors and GLP-1 agonists, which have a low risk of indu-
cing hypoglycemia. The duration of insulin therapy is
closely related to hypoglycemia risk in type 2 diabetes,
which rises progressively as pancreatic β-cell function
fails [3, 4, 24].
The incidence rate of severe hypoglycemia also de-
clined in people with type 2 diabetes treated with sulfo-
nylureas. This was associated with a decline in the use of
sulfonylureas from 36.8 to 22.4%, and may reflect avoid-
ance of their use in people at high risk of hypoglycemia.
People with type 2 diabetes who experienced severe
hypoglycemia were twice as likely to require hospital ad-
mission than those with type 1 diabetes (32% vs 16%),
which has been reported by another British study [25].
People with type 2 diabetes are more likely to be older
and more frail, both being risk factors that are associated
with severe hypoglycemia [26, 27].
During the period of the present study, the ambulance
service treated more episodes of severe hypoglycemia
without the need to transfer patients to hospital. The in-
crease in non-conveyance may have resulted from the
introduction in non-conveyance clinical guidelines for
post-hypoglycemia patients in 2005 [28].
The present study has some limitations. If an ambu-
lance had been called after a self-treated episode of
hypoglycemia had resolved, such an incident may not
have been recorded as a severe hypoglycemia event.
Hypoglycemia treated by General Practitioners (GP)
would not have been recorded. Some cases may have
been missed if the patients who had experienced severe
hypoglycemia had presented with another principal
complaint such as chest pain or the consequences of
trauma, and blood glucose had not been measured.
The present study indicates that around 9% (187 of
2029) of people with type 1 diabetes experienced severe
hypoglycemia that required emergency medical services,
which compares to 13% in a recent large prospective study
[29] that relied on self-reported data. When using self-
reported data the incidence rate of severe hypoglycemia in
type 2 diabetes has varied between 0.1 and 0.7 events per
person per year [1, 3, 6, 10, 24, 30]. This compares to
Table 5 Mean HbA1c levels with 95% confidence intervals in groups of people with types 1 or 2 diabetes who have had (or have
not had) hypoglycemia events requiring emergency medical services. b) Secretagogues e.g. sulfonylureas and glinides
Severe
hypoglycemia
June 1997–May 1998 January 2011–December 2012
Number of people Mean HbA1c (95% CI) Number of people Mean HbA1c (95% CI)
Type 1 No 908 7.93 (7.76–8.10) 1671 9.19 (5.45–12.93)
Yes 69 7.77 (7.29–8.25) 182 9.00 (5.76–12.23)
Type 2 b) No 2800 7.16 (7.08–7.23) 4772 7.93 (4.81–11.05)
Yes 23 8.00 (7.10–8.91) 47 7.60 (4.72–10.48)
Insulin No 835 8.23 (8.09–8.37) 3390 8.86 (5.16–12.56)
Yes 66 7.87 (7.47–8.28) 183 8.49 (4.97–12.02)
All diabetes No 8495 7.19 (7.14–7.24) 20,953 7.67 (4.21–11.13)
Yes 160 7.85 (7.57–8.14) 454 8.47 (4.98–11.95)
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incidence rates of emergency medical treatment in the
present study of 0.01 events per person per year for all
people with type 2 diabetes and 0.037 events per person
per year for those with insulin-treated type 2 diabetes
(Table 3). In other studies, the reported rates were much
lower at 0.017 events [31] and 0.003 events [32] per per-
son per year, respectively.
Conclusions
The present large population-based study over a 2-year
period has used data from different sources, and describes
routine experience of the involvement of emergency med-
ical services in the treatment of severe hypoglycemia. It
suggests that the incidence rates of severe hypoglycemia
requiring emergency medical services are declining both
in types 1 and 2 diabetes, although the absolute number
of events requiring emergency treatment is rising. While
the burden on the emergency medical services is greater,
with less duplication of service utilization and a significant
reduction of the number of people attending hospital for
treatment, provision may be more efficient than in previ-
ous years.
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